[1]
2019. Dusp6 inhibits epithelial-mesenchymal transition in endometrial adenocarcinoma via ERK signaling pathway: Dusp6 inhibits EMT in EAC via regulating ERK pathway. Radiology and Oncology. 53, 3 (Sep. 2019), 307–315.